The clinical severity of coronavirus disease 2019 (COVID-19) is largely determined by host
factors. Recent advances point to cellular senescence, an ageing-related switch in cellular …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …

Introduction of vaccines against COVID-19 has provided the most promising chance to
control the world-wide COVID-19 pandemic. However, the adenovirus-vector based …

Objective The objective of this study was to assess the impact of treatment with
dexamethasone, remdesivir or both on neurological complications in acute coronavirus …

Aiming to reduce mortality in COVID-19 with severe respiratory failure we administered a
combined rescue treatment (COMBI) on top of standard-of-care (SOC: dexamethasone …

Severe forms of coronavirus 2019 (COVID-19) disease are caused by an exaggerated
systemic inflammatory response and subsequent inflammation-related coagulopathy. Anti …

The corona virus disease 2019 (COVID-19) global pandemic has had an unprecedented
and persistent impact on oncological practice, especially for patients with lung cancer, who …

Objectives. There is a growing interest in understanding the association between Guillain‐
Barré syndrome (GBS) and SARS‐CoV‐2 infection. The aim of this study was to analyse …

It was previously reported that subjects with diabetes mellitus (DM) are more vulnerable to
several bacterial or viral infections. In the era of coronavirus disease 2019 (COVID-19) …

Global COVID-19 vaccination programs for children and adolescents have been developed
with international clinical trial data confirming COVID-19 mRNA vaccine safety and efficacy …